These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17394842)

  • 1. [News in rheumatology. The Danish Society of Rheumatology].
    Østergaard M; Steengaard-Pedersen K; Herlin T; Kjaer M; Døhn UM; Nørregaard J; Madsen OR;
    Ugeskr Laeger; 2007 Mar; 169(12):1131. PubMed ID: 17394842
    [No Abstract]   [Full Text] [Related]  

  • 2. [New trends in rheumatology. The Danish Society of Rheumatology].
    Andersen LS; Gam AN; Hansen A; Kollerup G; Rasmussen C; Rasmussen JM; Schiøttz-Christensen B; Slot O; Thamsborg G
    Ugeskr Laeger; 2003 Mar; 165(12):1255. PubMed ID: 12701305
    [No Abstract]   [Full Text] [Related]  

  • 3. The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines.
    Deighton C; Gadsby K
    Musculoskeletal Care; 2006 Sep; 4(3):174-81. PubMed ID: 17042028
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
    Hill J; Reay N
    Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
    [No Abstract]   [Full Text] [Related]  

  • 5. Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
    Silman A; Rudkin S; Walley T
    Rheumatology (Oxford); 2011 Aug; 50(8):1356-7. PubMed ID: 21118870
    [No Abstract]   [Full Text] [Related]  

  • 6. H1N1 virus and vaccination among rheumatology patients, especially those on DMARDS.
    O'Connor MB; Rathi J; Bond U; Swan J; Phelan M
    Ir Med J; 2010 Apr; 103(4):126-7. PubMed ID: 20491149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Continuous quick development of rheumatology].
    Madsen OR; Terslev L; Tarp U; Jacobsen S; Ostergaard M
    Ugeskr Laeger; 2009 Mar; 171(13):1092. PubMed ID: 19321087
    [No Abstract]   [Full Text] [Related]  

  • 8. Are individual patient trials (n-of-1 trials) in rheumatology worth the extra effort?
    Peloso PM
    J Rheumatol; 2004 Jan; 31(1):8-11. PubMed ID: 14705210
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI).
    Schaeverbeke T; Pham T; Richez C; Wendling D
    Joint Bone Spine; 2018 Jul; 85(4):399-402. PubMed ID: 29574143
    [No Abstract]   [Full Text] [Related]  

  • 10. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination recommendations of the Commission for Pharmacotherapy of the German Society of Rheumatology].
    Warnatz K; Goldacker S; Gause AM;
    Z Rheumatol; 2013 Sep; 72(7):687-9. PubMed ID: 23929238
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the British Society for Rheumatology Biologics Register (BSRBR) and the NICE guidelines for anti-TNF therapy.
    Watson K; Hyrich K
    Musculoskeletal Care; 2003 Mar; 1(1):58-64. PubMed ID: 20217664
    [No Abstract]   [Full Text] [Related]  

  • 13. Robin Goodfellow.
    Rheumatology (Oxford); 2001 Nov; 40(11):1322. PubMed ID: 11709624
    [No Abstract]   [Full Text] [Related]  

  • 14. Hotel-based rheumatology, and more.
    Leeb BF
    J Rheumatol; 2009 Feb; 36(2):455-6; author reply 456-7. PubMed ID: 19208582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic strategies: Ways to remission].
    Krüger K; Edelmann E
    Z Rheumatol; 2015 Jun; 74(5):386-7. PubMed ID: 26085071
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
    Woodworth TG; Furst DE; Strand V; Kempeni J; Fenner H; Lau CS; Miller F; Day R; Lipani J; Brooks P
    J Rheumatol; 2001 May; 28(5):1163-9. PubMed ID: 11361207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How and when to use DMARDs.
    Simmons S
    Nurse Pract; 2010 Aug; 35(8):12-4. PubMed ID: 20644444
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence based medicine in rheumatology].
    Gause A; Raspe HH
    Z Rheumatol; 2002 Oct; 61(5):516-8. PubMed ID: 12399877
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheumatologic rehabilitation: the great expectation for rheumatic patients.
    Maddali Bongi S; Matucci Cerinic M
    Reumatismo; 2012 Mar; 64(1):1-6. PubMed ID: 22472777
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.
    Gossec L; Bijlsma JW; Bombardier C; Canhão H; Devlin J; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Ostergaard M; Pereira IA; Ramos-Remus C; Zochling J; Dougados M
    Ann Rheum Dis; 2011 Feb; 70(2):388-9. PubMed ID: 20472594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.